Opaleye Management reports $31,687 Grace Therapeutics common share purchase

• Opaleye Management raised its stake in Grace Therapeutics to 2,855,318 shares, held indirectly through Opaleye, L.P.
• The fund bought 15,089 shares at USD 2.1 each in open-market purchases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-043996), on September 23, 2026, and is solely responsible for the information contained therein.